A patient should never have to choose between a medicine that works and a medicine they can afford. That is the gap SRGP exists to close.
What We Do
Screen. Register. Deliver.
01
Screen
VAIS™ researches disease profiles across Asia and identifies the best-in-class, blockbuster molecule in every category, benchmarking it against all available generations and screening each external supplier on efficacy, safety, and manufacturing quality.
02
Register
Genuine regulatory authority relationships compress dossier review and product registration timelines, market by market.
03
Deliver
Diversified sourcing and continuous supply monitoring keep every partner stocked, reliability as a daily discipline, practiced long after the contract is signed.
Focus Areas
Four categories, evaluated and sourced through VAIS™.
Our USP
VAIS™, the engine behind the promise
VAIS™ keeps you ahead of where the industry is heading, not chasing behind it. It means earlier access to the newest generation of best-in-class medicine, at a price that keeps it within reach. Read the full methodology →
Why Partner With SRGP
Your molecule's fastest, most trusted route to market.
For manufacturers and originators, we offer genuine regulatory authority relationships, an AI-informed view of exactly where your product stands against the competition, and a transparent commercial partnership built for long-term collaboration.
Start a Manufacturer Partnership
Trust & Compliance
NPRA
HSA
NMRA
Partnering